UpToDate vs Lexicomp (UpToDate Lexidrug): are they the same, and which do you need?

No, but they are not competitors either. UpToDate and Lexicomp are two different products sold by the same company, Wolters Kluwer. UpToDate is the clinical reference built from graded topic reviews written by physician authors. Lexicomp, which the vendor now sells as UpToDate Lexidrug, is the drug-information database built by pharmacists for pharmacists. They answer different questions, and the reason people assume they are the same is that Wolters Kluwer packages them together and uses one inside the other.

That last point is the one worth remembering. The drug content you see when you look up a medication inside UpToDate is Lexidrug content. So the two products are not parallel options on a shortlist; one supplies part of the other. If a colleague tells you their hospital "has Lexicomp", they hold a current Wolters Kluwer license to Lexidrug, and if a comparison you find online was written before the rename, it is still describing the product that exists today. The same naming tangle affects the drug-app comparison, which we cover in Epocrates vs Lexicomp.

UpToDate includes Lexidrug-sourced drug content, which is why drug monographs, dosing fields and interaction analysis appear when you look a medication up inside it. What that does not mean is that an UpToDate subscription gives you the full Lexidrug database. The integrated drug layer inside a clinical reference is a subset chosen to support the topic you are reading. The standalone product carries content sets that the integrated view does not surface, and which sets you get depends on the package your institution licensed.

The practical test is simple and takes a minute. Open the drug lookup inside your UpToDate access and search for the specific field you actually need, whether that is an IV compatibility check, a compounding stability figure or a neonatal dose. If it is there, you do not need a second subscription. If it is not, you need Lexidrug itself rather than more UpToDate. Do that test before you buy anything, because the single most common way US clinicians waste money on drug references is paying personally for access an employer already holds.

Here the two products from the same vendor behave completely differently, and it is the most useful thing a buyer can learn from this comparison. Lexidrug publishes a price you can read without talking to anyone: Apple's US App Store lists the in-app subscriptions, Lexicomp Professional Package and Lexi-COMPLETE, at $29.99, with new individual users getting a one-month trial of the Hospital Pharmacist package that then renews at $29.99 a month. Across a year that is roughly $360.

UpToDate publishes nothing. We checked store.uptodate.com again in August 2026 and it still shows no dollar figure anywhere; it routes you through a country selector and a professional-role selector before it will quote, and the iOS app carries no in-app purchases at all because access is sold on the web. You will find confident annual figures for UpToDate on software directory sites. Those numbers are not published by Wolters Kluwer, they disagree with each other, and we do not repeat them. The honest statement is that the vendor quotes individually, so the only reliable number is the one you are given for your own country and role. Our full breakdown of what UpToDate actually costs walks through how to get that quote, and the sister figures are in what Lexicomp and Lexidrug cost.

Lexicomp is a tertiary source, and so is UpToDate. In drug-information terms, primary sources are the original studies themselves, secondary sources are the indexes and databases that help you find those studies, such as PubMed or Embase, and tertiary sources are the compendia, textbooks and databases that compile and interpret the primary literature into usable summaries. Drug monographs, topic reviews and interaction databases all sit in that third category, however well referenced they are.

This matters more than it sounds when you are writing something up. Pharmacy students, residents and anyone preparing a drug-information response are usually expected to trace a claim back through the tertiary source to the primary study rather than cite the compendium as the last word. Both UpToDate and Lexidrug support that, because both reference the literature they are built from. Use them to find and frame the answer quickly, then follow the citation when the stakes or the audience require the original.

IV compatibility is a drug-database function, not a topic-review function, so it belongs on the Lexidrug side of this comparison rather than in UpToDate's clinical topics. Whether you can reach it depends entirely on which content package your institution licensed, because Wolters Kluwer sells compatibility content as part of specific Lexidrug configurations rather than including it universally. The only reliable way to know is to search for a known incompatible pair inside your own subscription and see whether the module returns a result.

This is the clearest example of why the "do I need both" question usually resolves in favor of Lexidrug for pharmacy teams and against a second subscription for most prescribers. If your work involves preparing or administering intravenous medications, the compatibility and stability content is the reason you need the standalone drug database. If you write prescriptions and someone else prepares them, you almost certainly do not, and the money is better spent on something that closes a gap you actually hit.

Both products are excellent at answering a question you have already thought to ask. Neither one watches the prescription in front of you and volunteers, without being asked, that this patient is already taking something that interacts with it, that their kidney function makes the standard dose wrong, or that a documented allergy rules out the obvious first choice. Getting all of that from a reference means knowing to run several separate lookups in a row, and prescribing errors cluster exactly where nobody thought to look.

That is the job Prescriber.io is built for. You enter the drug or the scenario once and it checks for drug-drug interactions, flags contraindications and allergy blockers, surfaces renal and hepatic dose adjustments, and suggests guideline-based alternatives, all together, with a cited source on each flag so you can confirm it. It is decision-support, not autonomous prescribing: every flag is a prompt for a licensed clinician who reviews it, verifies against official sources, and signs. If you came here weighing whether to keep paying for a reference at all, our UpToDate alternative and Lexicomp alternative pages cover that decision, and the wider field is laid out in our guide to the best clinical decision support software.